Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
---|---|---|---|---|---|---|
AbbVie | Botulinum toxin type a | Botox |  | 1991-12-09 |  |  |
Evolus | Botulinum toxin type a | Nuceiva |  | 2019-09-27 |  |  |
Ipsen | Botulinum toxin type a | Dysport |  | 2009-04-29 |  |  |
Merz | Botulinum toxin type a | Xeomin |  | 2010-07-30 |  |  |
Revance Therapeutics | Botulinum toxin type a | Daxxify |  | 2022-09-07 | $103.201 M | Q4/23-Q3/24 |
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
---|---|---|---|---|---|